Research on the New National System forthe R&D in Emergency in the Context of Major Public Health Emergencies:Taking China's COVID-19 Vaccine R&D as an Example
Fu Jinhua1, Cai Jinsong2
1. Chinese Academy of Science and Technology for Development, Beijing 100038, China; 2. School of Public Administration, Beihang University, Beijing 100191, China
Abstract：The construction of the new national system under the conditions of the socialist market economy is one of the important contents of the construction of China's S&T and innovation governance system and even the national governance system in the new era.This paper focuses on the application scenarios of major public health emergencies, takes the new national system for the R&D in Emergency as the research object, and concentrates on answering questions about the necessity of adopting the new national system for the R&D in Emergency and the realization mechanism based on the case of China's COVID-19 vaccine R&D.The study found that the new national system, relying on institutional advantages, can meet the special needs of R&D in major public health emergencies, and has become an effective institutional arrangement for the R&D in Emergency.The study also found that in order to exert its institutional effectiveness, the new national system for the R&D in emergency must pay attention to the role of some key influencing factors, including the division of labor and cooperation between the government and the market, the connection between the R&D in emergency and the R&D in normal, the collaboration between the central and local governments, and the overall coordination of domestic and international resources, etc.The COVID-19 vaccine R&D is the successful application of the new national system for the R&D in Emergency of key technologies.The main realization mechanisms include leadership mechanism, organizational mechanism, technology tackling mechanism, technology reserve mechanism, central-local coordination mechanism and open innovation mechanism.
傅晋华, 蔡劲松. 重大突发公共卫生事件背景下应急研发的新型举国体制研究:以新冠疫苗研发为例[J]. 中国科技论坛, 2023(4): 168-177.
Fu Jinhua, Cai Jinsong. Research on the New National System forthe R&D in Emergency in the Context of Major Public Health Emergencies:Taking China's COVID-19 Vaccine R&D as an Example. , 2023(4): 168-177.
2023, 
